<i>VHL</i> missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response.

导出 LinkOut

翻译打印收藏纠错

作者： Ziyang,Xu ^[1] ; Li,Liu ^[1] ; Wenbin,Jiang ^[1] ; Youqi,Qiu ^[1] ; Boyu,Zhang ^[1] ; Jiangting,Cheng ^[1] ; Jiyan,Luo ^[1] ; Jianming,Guo ^[2] ; Jiejie,Xu ^[3]

作者单位： Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. ^[1] Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China guo.jianming@zs-hospital.sh.cn jjxufdu@fudan.edu.cn. ^[2] NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China guo.jianming@zs-hospital.sh.cn jjxufdu@fudan.edu.cn. ^[3]

关键词 Biomarker Genome Immunotherapy Kidney Cancer

主题词人类(Humans);癌, 肾细胞(Carcinoma, Renal Cell);脑视网膜血管瘤抑制蛋白质(Von Hippel-Lindau Tumor Suppressor Protein);肾肿瘤(Kidney Neoplasms);突变, 误义(Mutation, Missense);免疫疗法(Immunotherapy);女(雌)性(Female);男(雄)性(Male);中年人(Middle Aged);肿瘤微环境(Tumor Microenvironment)

DOI 10.1136/jitc-2024-009963

PMID 39448203

发布时间 2024-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal for immunotherapy of cancer

2024年12卷10期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>VHL</i> missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>VHL</i> missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

检索历史清除